A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- David Miklos
- Target Recruit Count
- 15
- Registration Number
- NCT00760981
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath